Literature DB >> 12854026

Splenic T cells from mice receiving intracameral antigen suppress in-vitro antigen-induced proliferation and interferon-gamma production by sensitized lymph node cells.

Yafei Wang1, Wa-el Ghali, Pavani Pingle, Amar Traboulsi, Tajas Dalal, James O'Rourke, Robert E Cone.   

Abstract

PURPOSE: To characterize the immunoregulatory mechanisms in vitro of spleen cells that are activated by intracameral injection of antigen (AC-spleen cells).
METHODS: AC-spleen cell regulation of in-vitro antigen-induced proliferation and interferon-gamma production by lymph node cells from TNP-BSA-immunized mice was quantified by co-culture of the lymph node cells with TNP-BSA and AC-spleen cells induced by intracameral TNP-BSA. Cytokine production was quantified by ELISA.
RESULTS: AC-spleen cells produced significantly more IL-4 and IL-10 than spleen cells from TNP-BSA-immunized mice or naive spleen cells; unlike spleen cells from immunized mice, AC-spleen cells did not produce IFN-gamma. AC-splenic CD4(+), CD8(+), CD4(-)/CD8( -) (DN) T cells differentially suppressed antigen-induced proliferation and IFN-gamma production by immunized lymph node cells by a mechanism dependent on IL-10 and antigen. Cultures of lymph node cells, antigen, and AC-splenic T cells contained increased amounts of IL-10 and/or TGFbeta2.
CONCLUSIONS: The differential, cytokine-dependent immunoregulatory effects of CD4( +) and CD8(+) AC-spleen cells observed in vitro parallel their effects in vivo. We suggest that the suppression of antigen-induced lymphocyte proliferation and IFN-gamma production by AC-spleen cells provides a useful in-vitro assay of the immunoregulatory activity of cell populations that are induced by the injection of antigen into the anterior chamber.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854026     DOI: 10.1076/ocii.11.1.39.15578

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  8 in total

1.  Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.

Authors:  Sourojit Bhowmick; Robert B Clark; Stefan Brocke; Robert E Cone
Journal:  Int Immunol       Date:  2011-01-27       Impact factor: 4.823

2.  Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation.

Authors:  Liqiong Jiang; Hao He; Peizeng Yang; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-17       Impact factor: 3.117

3.  The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires interferon-gamma.

Authors:  Robert E Cone; Xingya Li; Roshanak Sharafieh; James O'Rourke; Anthony T Vella
Journal:  Immunology       Date:  2006-10-18       Impact factor: 7.397

4.  Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.

Authors:  Xingya Li; Yafei Wang; David Urso; James O'Rourke; Robert E Cone
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

5.  The suppression of hypersensitivity by ocular-induced CD8(+) T cells requires compatibility in the Qa-1 haplotype.

Authors:  Robert E Cone; Subhasis Chattopadhyay; Roshanak Sharafieh; Yen Lemire; James O'Rourke
Journal:  Immunol Cell Biol       Date:  2009-01-13       Impact factor: 5.126

6.  T cell sensitivity to TGF-beta is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber.

Authors:  Robert E Cone; Subhasis Chattopadhyay; Roshanak Sharafieh; Yen Lemire; James O'Rourke; Richard A Flavell; Robert B Clark
Journal:  Int Immunol       Date:  2009-03-26       Impact factor: 4.823

7.  Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.

Authors:  Hao He; Peizeng Yang; Liqiong Jiang; Junfeng Zhang; Changlin Zhao; Lina Chen; Xiaomin Lin; Hongyan Zhou; Aize Kijlstra
Journal:  BMC Immunol       Date:  2008-09-25       Impact factor: 3.615

8.  Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury.

Authors:  Beatriz Pineda-Rodriguez; Diana Toscano-Tejeida; Elisa García-Vences; Roxana Rodriguez-Barrera; Adrian Flores-Romero; Daniela Castellanos-Canales; Gabriel Gutierrez-Ospina; Laura Castillo-Carvajal; Esperanza Meléndez-Herrera; Antonio Ibarra
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.